Literature DB >> 30123968

Cutaneous adverse drug reaction after apomorphine infusion, possibly caused by a systemic type IV hypersensitivity reaction to sodium metabisulfite: Report of 2 cases.

Robbert W K Borgemeester1, Teus van Laar1, Marie L A Schuttelaar2.   

Abstract

Entities:  

Keywords:  CAS no. 7681-57-4; allergy; apomorphine; delayed-type hypersensitivity; sodium metabisulfite; systemic; type IV hypersensitivity

Mesh：

Substances：

Year:  2018        PMID： 30123968     DOI： 10.1111/cod.13058

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN： 0105-1873            Impact factor:   6.600


× No keyword cloud information.
  1 in total

1.  Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson's disease.

Authors:  Peter Hagell; Arja Höglund; Carina Hellqvist; Eva-Lena Johansson; Berit Löwed; Anne-Christine Sjöström; Carina Karlberg; Margareth Lundgren; Nil Dizdar; Anders Johansson; Thomas Willows; Johan Rådberg; Filip Bergquist
Journal:  J Neurol       Date:  2020-07-01       Impact factor: 4.849
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.